Adrenal Gland Function and Dysfunction During COVID-19

Area of Science:

• Endocrinology
• Infectious Diseases
• Pathology

Background:

• The COVID-19 pandemic presents significant global health and economic challenges.
• Adrenal hormone secretion is crucial for surviving infections, and glucocorticoids may aid COVID-19 patient recovery.
• Emerging evidence suggests SARS-CoV-2 may target adrenal glands, raising concerns about adrenal dysfunction.

Purpose of the Study:

• To review and discuss factors influencing adrenal gland function during COVID-19.
• To explore the potential for SARS-CoV-2 to cause adrenal dysfunction.
• To examine the implications of structural adrenal changes in COVID-19 patients.

Main Methods:

• Review of existing literature on COVID-19 and adrenal gland function.
• Analysis of histopathological findings related to SARS-CoV-2 infection in adrenal glands.
• Discussion of clinical observations regarding cortisol levels and adrenal insufficiency in COVID-19 patients.

Main Results:

• Histopathological evidence indicates SARS-CoV-2 can cause structural damage to adrenal glands, particularly the vasculature.
• Widespread cortical cell damage is not observed, making immediate adrenal crisis unlikely.
• Most COVID-19 patients exhibit adequate cortisol levels, but late-onset or milder adrenal insufficiency cannot be ruled out.

Conclusions:

• While direct, severe adrenal damage is rare in COVID-19, potential dysfunction exists.
• Critical illness-related corticosteroid insufficiency (CIRCI) and iatrogenic adrenal insufficiency are possible complications.
• Further research is needed to fully understand the long-term impact of COVID-19 on adrenal function.